• Press Release

Mount Sinai and Cross County Cardiology Partner to Expand Advanced Cardiac Services in New Jersey

  • New York, NY
  • (July 15, 2020)

Mount Sinai Health System and Cross County Cardiology announced a new cooperative partnership today that will include five cardiology practices located throughout Bergen and Hudson counties in New Jersey. Cross County Cardiology-Mount Sinai Doctors will work to enhance clinical care for patients with cardiovascular disease bringing the most advanced techniques within the field of cardiology and vascular care to the region.

“Cross County Cardiology is extremely honored to partner with Mount Sinai and the world-class team of cardiologists led by renowned heart specialist Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital and to offer our patients access to advancements in practice, diagnostics and treatment and other specialty care within the Mount Sinai Health System,” said Rick Pumill, MD, Director of Cross County Cardiology-Mount Sinai Doctors.

Ranked 6th nationally for Cardiology & Heart Surgery by U.S. News & World Report, Mount Sinai Heart at The Mount Sinai Hospital, is celebrated internationally as a world leader in all facets of cardiology care, cardiac surgery, and advanced research.

Patients will no longer need to travel across the Hudson River into New York City to receive their cardiac care as Cross County Cardiology-Mount Sinai Doctors will include five separate practice locations in New Jersey. The practices are located at 20 Prospect Ave Suite 909, Hackensack; 38 Meadowlands Parkway, Secaucus; 103 River Road, 2nd floor, Edgewater; 7322 Bergenline Avenue, North Bergen; and 92 Summit Ave, Hackensack. With the new partnership, Cross County-Cardiology-Mount Sinai Doctors will also offer additional sub specialty experts.

“Mount Sinai Health Network is excited to collaborate with Cross County Cardiology and to welcome this talented team of cardiac specialists in the New Jersey region into Mount Sinai’s growing network of hospitals, clinical practices, and polyclinics,” said Arthur Klein, MD, President of the Mount Sinai Health Network. “Patients seen in the practice will receive the highest standard of personalized cardiac care by highly trained doctors and staff who employ the latest medical protocols and innovative research to save lives.”

“Over the years, patients have become our best referral source and they have helped us to advance and grow our practice,” added Pumill. “We take pride in knowing that each and every patient encounter is a worthwhile experience and that all of our patients feel comfortable with their diagnosis and treatment plan. Patient care and safety is our number one concern.”


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.